If so could recover some. Plus big investors will double down here.
the ORIGINAL jump that took it over $30 was for LUNG cancer, not ovarian. The trial halted announced TODAY was for ovarian cancer
yes, that is what I understood, lung cancer not ovarian. But I don't know if the drug trials are completely being stopped for all avenues or not. Some explanations are due.
read the PR stupid.. It said ovarian.
Hmm..So, why is the big drop??
Those who invested at $21.00/share might double down at today's prices. That is highly likely.